Be My Guest: The Bridge Episode
GUIYANG, China, Feb. 24, 2025 /PRNewswire/ -- Guizhou, the only province in…
ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients
Approximately five months after launch, the inclusion of neffy on these three…
TUMI CELEBRATES 50TH ANNIVERSARY WITH CAMPAIGN, “MADE FOR YOU SINCE 1975”
With the customer as their muse, the brand showcases their icons and…
Global Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI Reports
MILPITAS, Calif., Feb. 18, 2025 /PRNewswire/ -- The global semiconductor manufacturing industry closed…
Hyundai Motor Group Welcomes Startups for 2025 ZER01NE Accelerator First Half Open Call
Hyundai Motor Group invites startups to apply for the 2025 first-half innovation…
Worldwide Silicon Wafer Shipments and Revenue Start Recovery in Late 2024, SEMI Reports
MILPITAS, Calif., Feb. 13, 2025 /PRNewswire/ -- In the second half of…
Grace Therapeutics Announces Third Fiscal Quarter 2025Financial Results, Provides Business Update
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical…
Cloud Market Jumped to $330 billion in 2024 – GenAI is Now Driving Half of the Growth
RENO, Nev., Feb. 7, 2025 /PRNewswire/ -- New data from Synergy Research…
Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe…
As Milano Cortina 2026 prepares to celebrate one year to go, second Winter Games Week gets underway
04 February 2025 - The Winter Games Weeks have already reached nearly half…